This website uses cookies

This websites contains videos from YouTube. This company uses cookies (third party cookies). If you do not want them to use these cookies, you can indicate so here. However, this does mean that you will not be able to watch videos on this website. We also make use of our own cookies in order to improve our website. We don't share our data with other parties. Which cookies are involved?

This website uses cookies to enable video and to improve the user experience. If you do not want to accept these cookies, indicate so here. Which cookies are involved?

Ga direct naar de inhoud, het hoofdmenu, het servicemenu of het zoekveld.

Back to overview
Duijst, Maxime

Maxime Duijst



I obtained my General Biology bachelor's degree at the University of the District Columbia, Washington DC, followed by completing the master 'Infection & Immunity" at Utrecht University, Utrecht in 2018.

Throughout 2018, I worked at the National Institute of Health (RIVM) working on several projects concerning lung diseases by developing B cell and T cell assays, mainly using flow cytometry.

As my research interest is very broad, I joined the project of Karin de Visser and Marleen Kok in February 2019 to study the relationship between, and the effect of the combination of chemotherapy with checkpoint inhibition, on suppressive immune cells and cancer cells isolated from metastatic breast cancer patients.